we have america and mmerck and coming in with generic insulin which is important with people with diabetes. >> it's a very complicated disease too. are they heading in the right direction in terms of their cooperation with technology companies because a lot of it seems to come from being able to monitor yourself and being able to give yourself the best treatment along the way too. >> we think there's a couple of things going on here. price pressure from insurance company which what we're seeing in the diabetes market is similar to glax co-a couple of years ago. there's a broader thing going on here. digital health is using technology to help patients manage their disease better and getting someone to have a better diet and exercise in some cases may have a more gant impact on their disease their some of the new drugs that are coming out. i think this is a big change that's happening in the drug world, but also across health care. >> it's not just about the insurer so it's about the pharmacy too. i look at what's going on in the u.s. and dumps a drug for eli lilly in the space. i guess they